Literature DB >> 11337281

P53 in bladder cancer: mechanism of action, prognostic value, and target for therapy.

J W Slaton1, W F Benedict, C P Dinney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11337281     DOI： 10.1016/s0090-4295(01)00968-2

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  10 in total

1.  The effect of a novel frizzled 8-related antiproliferative factor on in vitro carcinoma and melanoma cell proliferation and invasion.

Authors:  Kristopher R Koch; Chen-Ou Zhang; Piotr Kaczmarek; Joseph Barchi; Li Guo; Hanief M Shahjee; Susan Keay
Journal:  Invest New Drugs       Date:  2011-09-20       Impact factor: 3.850

2.  Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.

Authors:  A Quintero; J Alvarez-Kindelan; R J Luque; R Gonzalez-Campora; M J Requena; R Montironi; A Lopez-Beltran
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

3.  Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence.

Authors:  Danae Papadogianni; Nikolaos Soulitzis; Demetrios Delakas; Demetrios A Spandidos
Journal:  Tumour Biol       Date:  2013-11-11

4.  Lymphoepithelioma-like carcinoma of the bladder: three cases with clinicopathological and p53 protein expression study.

Authors:  Francisco Miguel Izquierdo-García; Fructuoso García-Díez; Isabel Fernández; Alberto Pérez-Rosado; Anabel Sáez; Dimas Suárez-Vilela; Rafael Guerreiro-González; Manuel Benéitez-Alvarez
Journal:  Virchows Arch       Date:  2004-04-06       Impact factor: 4.064

5.  Expression of the polycomb group protein EZH2 and its relation to outcome in patients with urothelial carcinoma of the bladder.

Authors:  Stefan Hinz; Carsten Kempkensteffen; Frank Christoph; Michèle Hoffmann; Hans Krause; Mark Schrader; Martin Schostak; Kurt Miller; Steffen Weikert
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-11       Impact factor: 4.553

6.  Radiation induces p53-dependent cell apoptosis in bladder cancer cells with wild-type- p53 but not in p53-mutated bladder cancer cells.

Authors:  Nobuyuki Hinata; Toshiro Shirakawa; Zhujun Zhang; Akira Matsumoto; Masato Fujisawa; Hiroshi Okada; Sadao Kamidono; Akinobu Gotoh
Journal:  Urol Res       Date:  2003-09-04

7.  Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells.

Authors:  Hanief M Shahjee; Kristopher R Koch; Li Guo; Chen-Ou Zhang; Susan K Keay
Journal:  J Exp Clin Cancer Res       Date:  2010-12-10

8.  Cell density related gene expression: SV40 large T antigen levels in immortalized astrocyte lines.

Authors:  Phyllis S Frisa; James W Jacobberger
Journal:  BMC Cell Biol       Date:  2002-04-17       Impact factor: 4.241

9.  The expression patterns of p53 and p16 and an analysis of a possible role of HPV in primary adenocarcinoma of the urinary bladder.

Authors:  Riley E Alexander; Sean R Williamson; Justin Richey; Antonio Lopez-Beltran; Rodolfo Montironi; Darrell D Davidson; Muhammad T Idrees; Carol L Jones; Shaobo Zhang; Lisha Wang; Qiu Rao; Jose A Pedrosa; Hristos Z Kaimakliotis; M Francesca Monn; Michael O Koch; Liang Cheng
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

10.  Progression of urothelial carcinoma in situ of the urinary bladder: a switch from luminal to basal phenotype and related therapeutic implications.

Authors:  Isabella Barth; Ursula Schneider; Tobias Grimm; Alexander Karl; David Horst; Nadine T Gaisa; Ruth Knüchel; Stefan Garczyk
Journal:  Virchows Arch       Date:  2018-04-13       Impact factor: 4.064
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.